ArticleScientific reports2021

Tissue factor pathway inhibitor upregulates CXCR7 expression and enhances CXCL12-mediated migration in chronic lymphocytic leukemia.

Xue Yan Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.